Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 24, Issue 6, 2006, Pages 643-648

  Arman, Ahmet ^a   Yilmaz, B ^a   Coker, A ^a   Inanc, N ^a   Direskeneli, H ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

IL 1B and IL 1RN polymorphism; Rheumatoid arthritis

Indexed keywords

CYTOSINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; METHOTREXATE; PREDNISOLONE; THYMIDINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; TURKEY (REPUBLIC);

ALLELES; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TURKEY;

EID: 33846435181     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. CHOY EH, PANAYI GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907-16.
2. SHARMA PK, HOTA D, PANDHI P: Biologics in rheumatoid arthritis. J Assoc Physicians India 2004; 52: 231-6.
3. AKAR S, BIRLIK M, GURLER O et al.: The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 2004; 22: 416-20.
4. KACAR C, GILGIL E, TUNCER T et al.: Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 2005; 24: 212-4.
5. JOHN S, WORTHINGTON J: Genetic epidemiology. Approaches to the genetic analysis of rheumatoid arthritis. Arthritis Res 2001; 3: 216-20.
6. LIN JP, HIRSCH R, JACOBSSON LT et al.: Genealogy construction in a historically isolated-population: application to genetic studies of rheumatoid arthritis in the -Pima Indian. Genet Med 1999; 1: 187-93.
7. SARUHAN-DIRESKENELI G: Istanbul Rheumatology Study Group. Shared epitope homozygosity' is strongly associated with rheumatoid arthritis in Turkey. Br J Rheumatol 1998; 37: 1126-8.
8. AREND WP, DAYER JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995; 38: 151-60.
9. SUZUKI T: Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998; 41: 2196-204.
10. TARLOW JK, BLAKEMORE AI, LENNARD A, SOLARI R, HUGHES HN, STEINKASSERER A: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-4.
11. DANIS VA, MILLINGTON M, HYLAND VJ, GRENNAN D: Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-10.
12. di GIOVINE FS, TAKHSH E, BLAKEMORE AI, DUFF GW: Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1: 450.
13. POCIOT F, MOLVIG J, WOGENSEN L, WORSAAE H, NERUP J: A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
14. BLAKEMORE AI, COX A, GONZALEZ AM et al.: Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97: 369-74.
15. TJERNSTROM F, HELLMER G, NIVED O, TRUEDSSON L, STURFELT G: Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus. Lupus 1999; 8: 103-8.
16. BUCHS N, DI GIOVINE FS, SILVESTRI T, VANNIER E, DUFF GW, MIOSSEC P: IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun 2001; 2: 222-8.
17. PAWLIK A, KURZAWSKI M, FLORCZAK M, GAWRONSKA SZKLARZ B, HERCZYNSKA M: IL1beta +3953 exon 5 and IL-2-330 promoter polymorphisms in patients with rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 159-64.
18. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
19. MILLER SA, DYKES DD, POLESKY HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
20. EASTGATE JA, SYMONS JA, WOOD NC, GRINLINTON FM, DI GIOVINE FS, DUFF GW: Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988; 2: 706-9.
21. AREND WP. DUFF GW: Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest. 1991; 88: 1445-51.
22. PERRIER S, COUSSEDIERE C, DUBOST JJ, ALBUISSON E, SAUVEZIE B: IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol. 1998; 87: 309-13.
23. VAMVAKOPOULOS JE, TAYLOR CJ, MORRIS-STIFF GJ, GREEN C, METCALFE S: The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur J Immunogenet. 2002; 29: 337-40.
24. DANIS VA, MILLINGTON M, HYLAND VJ, GRENNAN D: Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995; 99: 303-10.
25. MANSFIELD JC, HOLDEN H, TARLOW JK et al.: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-42.
26. MARTINEZ A, PASCUAL M, PASCUAL-SALCEDO D, BALSA A, MARTIN J, de la CONCHA EG: Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun. 2003; 4: 117-21.
27. McGARRY F, NEILLY J, ANDERSON N, STURROCK R, FIELD M: A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford) 2001; 40: 1359-64.
28. JAVOSAVA K, NEMCOVA D, RUZICKOVA S et al: Interleukin 1 receptor antagonist gene allele 2 increased in patients with juvenile idiopathic arthritis. Ann Rheum Dis 2000; 59 (Suppl. 1): 253.
29. HURME M, SANTTILA S: IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998; 28: 2598-602.
30. CANTAGREL A, NAVAUX F, LOUBET-LESCOULIE P et al.: Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 1999; 42: 1093-100.
31. HUANG CM, TSAI FJ, WU JY, WU MC: Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis. Scand J Rheumatol. 2001; 30: 225-8.
32. LEE YH, KIM HJ, RHO YH, CHOI SJ, JI JD, SONG GG: Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis. Rheumatol Int. 2004; 24: 133-6.
33. DINARELLO CA, WOLFF SM: The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106-13.
34. HALL SK, PERREGAUX DG, GABEL CA et al.: Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum. 2004; 50: 1976-83.
35. GENEVAY S, DI GIOVINE FS, PERNEGER TV et al.: Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum. 2002; 47: 303-9.
36. CAMARGO JF, CORREA PA, CASTIBLANCO J, ANAYA JM: Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 2004; 5: 609-14.
37. PARKS CG, COOPER GS, DOOLEY MA et al.: Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 2004; 63: 91-94.
38. HUANG CM, WU MC, WU JY, TSAI FJ: Lack of association of interleukin-1beta gene polymorphisms in Chinese patients with systemic lupus erythematosus. Rheumatol Int. 2002; 21: 173-5.
39. DOMINICI R, MALFERRARI G, MARIANI C, GRIMALDI L, BIUNNO I: The Interleukin 1beta exonic (+3953) polymorphism does not alter in vitro protein secretion. Exp Mol Pathol 2002; 73: 139-41.
40. ZHANG X, LLAMADO L, PILLAY I, PRICE P, WILL R: Interleukin-1 gene polymorphism disease activity and bone mineral metabolism in rheumatoid arthritis. Chin Med J (Engl). 2002; 115: 46-9.
41. CVETKOVIC JT, WALLBERG-JONSSON S, STEGMAYR B, RANTAPAA DAHLQVIST S, LEFVERT AK: Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. J Rheumatol 2002; 29: 212-9.
42. KAIJZEL EL, van DONGEN H, BAKKER AM, BREEDVELD FC, HUIZINGA TW, VERWEIJ CL: Relationship of polymorphisms of the Interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis. Tissue Antigens 2002; 59: 122-6.
43. RAVINDRAN JS, OWEN P, LAGAN A et al.: Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 2004; 43: 22-6.